Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impact of a 10-week individualized exercise program on physical function and fatigue of people with multiple sclerosis: a pilot study.
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Management of psoriasis vulgaris and multiple sclerosis with fumaric acid.
Multiple sclerosis in New Zealand Māori.
A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility.
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications.
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.
Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
Altered transition metal homeostasis in the cuprizone model of demyelination.
Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
Two assessments to evaluate imagery ability: translation, test-retest reliability and concurrent validity of the German KVIQ and Imaprax.
Th1-mediated experimental autoimmune encephalomyelitis is CXCR3-independent.
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis.
Mortality in patients with multiple sclerosis.
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
Relapsing optic neuritis: a multicentre study of 62 patients.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Pages
« first
‹ previous
…
423
424
425
426
427
428
429
430
431
…
next ›
last »